Stuart Titus
Director/Board Member bei GREEN GLOBE INTERNATIONAL, INC.
Vermögen: 36 107 $ am 31.03.2024
Profil
Stuart W.
Titus is the founder of General Hemp LLC, which was founded in 2012, where he holds the title of President.
Currently, he is a Director at Green Globe International, Inc. since 2021.
Dr. Titus's former jobs include being the Chairman, President & Chief Executive Officer at Medical Marijuana, Inc. from 2019 to 2021, Chairman at Hempacco Co., Inc. from 2021 to 2023, and Vice President at First Boston Corp.
from 1983 to 1989.
He was also a Director at Neuropathix, Inc. Dr. Titus's education history includes an undergraduate degree from Rollins College (Florida).
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
HEMPACCO CO., INC.
0,69% | 19.10.2023 | 21 621 ( 0,69% ) | 36 107 $ | 31.03.2024 |
Aktive Positionen von Stuart Titus
Unternehmen | Position | Beginn |
---|---|---|
GREEN GLOBE INTERNATIONAL, INC. | Director/Board Member | 22.03.2021 |
General Hemp LLC | Founder | 01.10.2012 |
Ehemalige bekannte Positionen von Stuart Titus
Unternehmen | Position | Ende |
---|---|---|
HEMPACCO CO., INC. | Chairman | 26.10.2023 |
MEDICAL MARIJUANA, INC. | Chief Executive Officer | 17.06.2021 |
First Boston Corp. | Corporate Officer/Principal | 01.11.1989 |
NEUROPATHIX, INC. | Director/Board Member | - |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | - |
Ausbildung von Stuart Titus
Rollins College (Florida) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
GREEN GLOBE INTERNATIONAL, INC. | Commercial Services |
MEDICAL MARIJUANA, INC. | Process Industries |
HEMPACCO CO., INC. | Consumer Non-Durables |
Private Unternehmen | 4 |
---|---|
First Boston Corp. | Finance |
General Hemp LLC | |
Credit Suisse First Boston Corp. | Finance |
Neuropathix, Inc.
Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA. | Health Technology |